Global Generic Drugs Market
According to Intent Market Research, the Generic Drugs Market is expected to grow from USD 431.1 billion in 2024-e at a CAGR of 8.8% to touch USD 775.8 billion by 2030. The Generic Drugs Market is dominated by key players such as Teva Pharmaceutical Industries Ltd., Sandoz (a Novartis division), Mylan N.V. (now part of Viatris), Sun Pharmaceutical Industries Ltd., Cipla Ltd., Lupin Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Amgen Inc., Aurobindo Pharma Ltd., Fresenius Kabi AG, Apotex Inc., Hetero Healthcare Ltd., Viatris Inc., Torrent Pharmaceuticals Ltd., Zydus Cadila Healthcare Ltd.